{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.4","value":"7.9"},{"groupId":"OG001","spread":"16.4","value":"7.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Appetite Loss"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.7","value":"1.0"},{"groupId":"OG001","spread":"23.7","value":"6.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Appetite Loss"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.2","value":"-0.5"},{"groupId":"OG001","spread":"20.2","value":"2.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Appetite Loss"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.3","value":"-1.6"},{"groupId":"OG001","spread":"19.9","value":"-1.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Appetite Loss"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.3","value":"0.5"},{"groupId":"OG001","spread":"20.1","value":"-1.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Appetite Loss"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.2","value":"9.8"},{"groupId":"OG001","spread":"19.0","value":"9.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Constipation"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.4","value":"1.0"},{"groupId":"OG001","spread":"22.6","value":"4.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Constipation"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.6","value":"3.4"},{"groupId":"OG001","spread":"23.1","value":"7.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Constipation"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.7","value":"4.1"},{"groupId":"OG001","spread":"23.3","value":"3.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Constipation"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.2","value":"3.2"},{"groupId":"OG001","spread":"24.6","value":"4.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Constipation"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.6","value":"8.8"},{"groupId":"OG001","spread":"14.9","value":"6.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Diarrhea"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.3","value":"-1.6"},{"groupId":"OG001","spread":"19.5","value":"-1.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Diarrhea"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.4","value":"-0.4"},{"groupId":"OG001","spread":"17.5","value":"-2.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Diarrhea"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.5","value":"-3.4"},{"groupId":"OG001","spread":"18.3","value":"-1.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Diarrhea"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.9","value":"-2.8"},{"groupId":"OG001","spread":"18.4","value":"-1.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Diarrhea"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.7","value":"12.7"},{"groupId":"OG001","spread":"18.8","value":"11.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Dyspnea"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.9","value":"2.3"},{"groupId":"OG001","spread":"22.4","value":"4.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Dyspnea"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.2","value":"2.8"},{"groupId":"OG001","spread":"20.4","value":"2.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Dyspnea"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.8","value":"3.3"},{"groupId":"OG001","spread":"22.7","value":"3.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Dyspnea"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.9","value":"3.9"},{"groupId":"OG001","spread":"22.4","value":"5.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Dyspnea"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.1","value":"29.2"},{"groupId":"OG001","spread":"20.0","value":"28.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Fatigue"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.1","value":"1.1"},{"groupId":"OG001","spread":"19.7","value":"5.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Fatigue"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.5","value":"1.1"},{"groupId":"OG001","spread":"21.3","value":"3.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Fatigue"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.9","value":"-1.4"},{"groupId":"OG001","spread":"22.2","value":"-0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Fatigue"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.3","value":"-0.1"},{"groupId":"OG001","spread":"22.1","value":"-0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Fatigue"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"33.3","value":"28.6"},{"groupId":"OG001","spread":"31.9","value":"27.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"604"},{"groupId":"OG001","value":"635"}],"units":"Participants"}],"title":"Baseline: Financial Difficulties"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.5","value":"-3.1"},{"groupId":"OG001","spread":"28.0","value":"-3.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"530"},{"groupId":"OG001","value":"548"}],"units":"Participants"}],"title":"Change at Cycle 5: Financial Difficulties"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"27.6","value":"-5.1"},{"groupId":"OG001","spread":"28.7","value":"-1.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"472"},{"groupId":"OG001","value":"480"}],"units":"Participants"}],"title":"Change at Cycle 11: Financial Difficulties"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"28.3","value":"-8.4"},{"groupId":"OG001","spread":"30.6","value":"-6.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"393"},{"groupId":"OG001","value":"444"}],"units":"Participants"}],"title":"Change at FU Month 6: Financial Difficulties"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"30.5","value":"-10.9"},{"groupId":"OG001","spread":"31.0","value":"-7.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"367"},{"groupId":"OG001","value":"413"}],"units":"Participants"}],"title":"Change at FU Month 12: Financial Difficulties"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"30.8","value":"30.6"},{"groupId":"OG001","spread":"29.2","value":"30.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Insomnia"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"28.4","value":"1.9"},{"groupId":"OG001","spread":"29.7","value":"1.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Insomnia"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"29.9","value":"2.4"},{"groupId":"OG001","spread":"30.3","value":"1.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"494"},{"groupId":"OG001","value":"494"}],"units":"Participants"}],"title":"Change at Cycle 11: Insomnia"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"31.3","value":"1.8"},{"groupId":"OG001","spread":"32.1","value":"-0.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Insomnia"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"30.4","value":"0.3"},{"groupId":"OG001","spread":"31.7","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Insomnia"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.0","value":"3.3"},{"groupId":"OG001","spread":"8.0","value":"2.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Nausea/Vomiting"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.2","value":"1.5"},{"groupId":"OG001","spread":"12.5","value":"3.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Nausea/Vomiting"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.8","value":"1.3"},{"groupId":"OG001","spread":"11.8","value":"3.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Nausea/Vomiting"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.4","value":"0.8"},{"groupId":"OG001","spread":"11.1","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Nausea/Vomiting"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.5","value":"0.4"},{"groupId":"OG001","spread":"10.9","value":"1.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Nausea/Vomiting"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.2","value":"22.2"},{"groupId":"OG001","spread":"22.8","value":"22.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Pain"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.2","value":"0.0"},{"groupId":"OG001","spread":"23.9","value":"1.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Pain"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.1","value":"0.1"},{"groupId":"OG001","spread":"24.4","value":"2.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Pain"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.6","value":"-0.3"},{"groupId":"OG001","spread":"24.3","value":"-0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Pain"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.6","value":"-1.2"},{"groupId":"OG001","spread":"25.4","value":"-0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Pain"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.2","value":"83.3"},{"groupId":"OG001","spread":"19.0","value":"84.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Cognitive Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.4","value":"-3.8"},{"groupId":"OG001","spread":"18.7","value":"-4.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Cognitive Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.3","value":"-5.4"},{"groupId":"OG001","spread":"19.6","value":"-5.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Cognitive Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.0","value":"-4.1"},{"groupId":"OG001","spread":"21.6","value":"-6.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Cognitive Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.2","value":"-4.9"},{"groupId":"OG001","spread":"21.7","value":"-6.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Cognitive Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.0","value":"75.0"},{"groupId":"OG001","spread":"21.2","value":"75.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Emotional Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.0","value":"-0.4"},{"groupId":"OG001","spread":"21.3","value":"-1.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Emotional Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.3","value":"-1.0"},{"groupId":"OG001","spread":"22.0","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Emotional Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.0","value":"-2.9"},{"groupId":"OG001","spread":"23.3","value":"-0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Emotional Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.7","value":"-2.0"},{"groupId":"OG001","spread":"23.5","value":"-1.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Emotional Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.3","value":"84.5"},{"groupId":"OG001","spread":"14.1","value":"85.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Physical Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.9","value":"0.3"},{"groupId":"OG001","spread":"12.7","value":"-1.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Physical Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.2","value":"1.9"},{"groupId":"OG001","spread":"14.6","value":"-0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Physical Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.4","value":"2.8"},{"groupId":"OG001","spread":"15.1","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Physical Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.5","value":"2.7"},{"groupId":"OG001","spread":"14.5","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Physical Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.0","value":"77.5"},{"groupId":"OG001","spread":"23.3","value":"78.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Role Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.3","value":"2.0"},{"groupId":"OG001","spread":"24.1","value":"-0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Role Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.3","value":"4.0"},{"groupId":"OG001","spread":"24.5","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Role Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.8","value":"7.4"},{"groupId":"OG001","spread":"26.7","value":"3.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Role Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"27.5","value":"8.0"},{"groupId":"OG001","spread":"25.5","value":"4.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Role Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.1","value":"77.1"},{"groupId":"OG001","spread":"23.2","value":"76.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Social Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.5","value":"4.0"},{"groupId":"OG001","spread":"23.8","value":"1.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Social Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.0","value":"5.8"},{"groupId":"OG001","spread":"23.6","value":"2.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Social Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.7","value":"8.5"},{"groupId":"OG001","spread":"26.1","value":"6.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Social Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.1","value":"9.5"},{"groupId":"OG001","spread":"26.4","value":"7.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Social Functioning"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.3","value":"71.2"},{"groupId":"OG001","spread":"18.0","value":"71.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"624"},{"groupId":"OG001","value":"645"}],"units":"Participants"}],"title":"Baseline: Global Health Status"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.9","value":"0.6"},{"groupId":"OG001","spread":"19.6","value":"-1.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"558"},{"groupId":"OG001","value":"571"}],"units":"Participants"}],"title":"Change at Cycle 5: Global Health Status"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.8","value":"1.7"},{"groupId":"OG001","spread":"19.9","value":"-0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"496"},{"groupId":"OG001","value":"496"}],"units":"Participants"}],"title":"Change at Cycle 11: Global Health Status"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.3","value":"2.5"},{"groupId":"OG001","spread":"19.2","value":"2.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"462"}],"units":"Participants"}],"title":"Change at FU Month 6: Global Health Status"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.5","value":"3.2"},{"groupId":"OG001","spread":"20.1","value":"2.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"384"},{"groupId":"OG001","value":"430"}],"units":"Participants"}],"title":"Change at FU Month 12: Global Health Status"}],"denoms":[{"counts":[{"groupId":"OG000","value":"743"},{"groupId":"OG001","value":"743"}],"units":"Participants"}],"description":"The EORTC QLQ-C30 consists of 30 questions which assess five functional domains (physical, role, cognitive, emotional, and social), a global health status/quality of life (GHS/QoL) scale, three symptom scales (fatigue, pain, nausea, and vomiting), five single items (dyspnea, appetite loss, sleep disturbance, constipation, and diarrhea), and a perceived financial impact of the disease item. Most questions used a 4-point scale (1= Not at all to 4 = Very much; 2 questions used a 7-point scale \\[1 = very poor to 7 = Excellent\\]). Obtained scores are linearly transformed to a score range of 0-100, whereby higher scores indicate greater functioning, greater quality of life, or a greater degree of symptoms. A positive change from baseline indicates improvement.","dispersionType":"Standard Deviation","groups":[{"description":"Participants received trastuzumab, 6 mg/kg, IV, Q3W, as a maintenance dose for 14 cycles (1 cycle = 21 days) or until disease recurrence or unacceptable toxicity which ever occurs first.","id":"OG000","title":"Trastuzumab"},{"description":"Participants received trastuzumab emtansine, 3.6 mg/kg, IV, Q3W for 14 cycles (1 cycle = 21 days) or until disease recurrence or unacceptable toxicity which ever occurs first.","id":"OG001","title":"Trastuzumab Emtansine"}],"paramType":"MEAN","populationDescription":"ITT population included all participants who were randomized to the study regardless of whether they received any study treatment. Overall number analyzed is the number of participants with data available for analysis. Number analyzed per timepoint are unique number of participants out of all the assessed participants with data available for analysis at the specified timepoint. Different participants may have contributed data for each timepoint.","reportingStatus":"POSTED","timeFrame":"Baseline, Cycles 5 &11, Follow-up (FU) Month 6, FU Month 12 (1 cycle = 21 days)","title":"Change From Baseline in European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire - Core 30 (QLQ-C30)","type":"SECONDARY","unitOfMeasure":"score on a scale"}